Morocco: Kelix bio to acquire PHI with proceeds from funding round led by DPI and CDC/BII

Kelix bio, a pan-African specialty generic business, is acquiring Morocco-based Pharmaceutical Institute (PHI), a producer and distributor of generic and therapeutic pharmaceuticals. The acquisition, which will be financed through up to a US$200m second round of funding into Kelix bio led by Development Partners International (DPI) and the UK development finance institution CDC Group (soon…

You must be a HMI Subscriber to view this content.

Subscribe Now »